Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end‐stage cancer patie...
Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end‐stage cancer patient
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Recent advances in mass spectrometry (MS)‐based technologies are now set to transform translational cancer proteomics from an idea to a practice. Here, we present a robust proteomic workflow for the analysis of clinically relevant human cancer tissues that allows quantitation of thousands of tumor proteins in several hours of measuring time and a t...
Alternative Titles
Full title
Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end‐stage cancer patient
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6e9918e8416d41e08b62caaacc33540a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6e9918e8416d41e08b62caaacc33540a
Other Identifiers
ISSN
1574-7891
E-ISSN
1878-0261
DOI
10.1002/1878-0261.12326
